scholarly journals Topical antibacterial therapy in the practice of otolaryngologist

2019 ◽  
pp. 10-17
Author(s):  
V. M. Svistushkin ◽  
E. A. Shevchik

The article highlights the problem of treating the most urgent inflammatory diseases of the upper respiratory tract, namely acute rhinosinusitis and acute otitis media in adults and children. The data on the use of topical antibacterial drugs in the treatment of these diseases is presented. Local antibacterial therapy of the inflammatory diseases of the upper respiratory tract can significantly increase the effectiveness of treatment without the risk of unwanted drug reactions and antibiotic resistance.

2016 ◽  
Vol 1 (1) ◽  
pp. 44-49 ◽  
Author(s):  
A. L. Zaplatnikov ◽  
A. A. Girina ◽  
I. V. Lepiseva

The article tells about the etiology of acute tonsillitis, pharyngitis, sinusitis and acute otitis media in children; there is data on the sensitivity of the bacterial pathogens of the infectious and inflammatory diseases of the respiratory tract to the most commonly prescribed antibiotics. The focus is on the global spread of antibiotic resistance of pathogens and questions of restraining its further acceleration. Approaches to the rational use of antibiotics for bacterial infections of the upper respiratory tract are discussed. Benefits of antibiotics in dispersible tablets are demonstrated. Algorithms for the primary selection of antibiotics for acute bacterial tonsillitis, pharyngitis, sinusitis and acute otitis media in children are suggested.


2019 ◽  
pp. 105-108
Author(s):  
A. A. Krivopalov ◽  
V. A. Shatalov ◽  
S. V. Shervashidze

According to WHO, the respiratory system diseases are currently inside the ten most common pathologies. The modern strategy for treating influenza and ARVI gives priority to the antiviral and immunostimulating agents, but the symptomatic drugs, which include preparations based on silver and its compounds, also play an important role. The large positive experience in using silver preparations supported by numerous clinical studies shows their high efficacy and satisfactory safety profile in the treatment of infectious and inflammatory diseases of the nose and upper respiratory tract in children and adults.


2021 ◽  
pp. 127-133
Author(s):  
A. V. Gurov ◽  
A. V. Muzhichkova

The article provides data on the effectiveness of the use of the drug in the treatment of acute, chronic and recurrent diseases of the respiratory tract and ENT organs. The drug is an extract of Pelargonium sidoides. From the standpoint of modern pharmacology, it is known that the use of natural products based on plant materials ensures safety and the absence of pronounced side effects. The main active ingredients of pelargonium are phenolic compounds: coumarins, flavonoids and phenolic acids. The article details the biochemical and pharmacological properties of each of the above groups of compounds. It has been shown that the presence of several classes of phenolic compounds simultaneously contributes to the potentiation of the pharmacological effects of each group separately. Therefore, drug has a pronounced polytropic effect: antiviral, antibacterial, immunomodulatory, mucolytic, anti-inflammatory, antioxidant, cytoprotective. The article presents the results of numerous domestic and foreign randomized, placebo-controlled studies demonstrating its high efficacy and safety in the treatment of ENT diseases, upper respiratory tract infections and bronchitis, not only in adults, but also in children over 1 year old. On the basis of the analyzed and presented material, the authors concluded that the use of a natural-based drug in the treatment of acute respiratory infection is effective and safe, both as monotherapy and in combination with other medicinal substances. He is able to quickly eliminate not only the symptoms of inflammation, but also to support the body with any ailments of this type.


Sign in / Sign up

Export Citation Format

Share Document